XTL Biopharmaceuticals Sponsored ADR had a revenue of 289.00K in the quarter ending Dec 31, 2024, with 78.40%. This bring the company's revenue in the last twelve months to 451.00K, Decreased 178.40%. In the fiscal year ending Dec 31, 2024, XTL Biopharmaceuticals Sponsored ADR had annual revenue of 451.00K with Infinity% growth.